Panion Animal Health AB logo

PANION - Panion Animal Health AB News Story

SEK0.602 0.0  0.0%

Last Trade - 27/09/19

Sector
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1831

BRIEF-Panion's Board Of Directors Evaluates Development Plan, Terminates Study Before Any Enrolment

Fri 6th September, 2019 5:54pm
Sept 6 (Reuters) - Panion Animal Health AB  PANION.TE :
    * PANION'S BOARD OF DIRECTORS EVALUATES DEVELOPMENT PLAN,
TERMINATES STUDY BEFORE ANY ENROLMENT, AND WITHDRAWS INAD
APPLICATION TO AVOID SUBSTANTIAL FEES.
    * PANION - AT BOARD MEETING ON SEPT 6, DEVELOPMENT PLAN FOR
PANION'S GENE THERAPY PRODUCT FOR TREATMENT OF DRUG-REFRACTORY
EPILEPSY WAS DISCUSSED
    * PANION ANIMAL -BOARD DECIDED TO WITHDRAW OPEN
INVESTIGATIONAL
NEW ANIMAL DRUG APPLICATION AT THIS STAGE TO AVOID FEE FOR
COMING FISCAL YEAR 2020
    * NO NEGATIVE EVENT HAS OCCURRED IN PLANNING OF STUDY OR
WITH
PRODUCT

Source text for Eikon:  ID:nWkr2FTVCS 
Further company coverage:  PANION.TE 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.